Sean McMillan, DO, became the first surgeon to use the Bear anterior cruciate ligament implant in New Jersey, ROI-NJ reported Feb. 3.

The California Institute of Regenerative Medicine has provided a $1.3 million grant to Kevin Stone, MD, chair of the Stone Research Foundation, and Mani Vessal, PhD, senior director of research and operation for the foundation, to advance a paste graft technique for cartilage repair.

Timothy Scannell, former president and COO at Stryker, was added to the board of directors at Collagen Matrix.

Life sciences company BioRestorative Therapies has been named one of the 10 most innovative regenerative medicine companies in 2022 by Insights Care Magazine.

Bone Solutions, an orthopedic devicemaker, launched the Mg Osteoinject bone void filler.

More spine and orthopedic surgeons are bringing regenerative medicine to their practices. 

Researchers sought to examine the effectiveness of intradiscal biologics for treating discogenic low back pain and found low-quality evidence supporting it, according to a study published in the February 2022 edition of The Spine Journal.

Regenerative medicine in orthopedic surgery has remained an area of interest among Becker's readers in 2021.

Brian Domby, MD, of Florida Medical Clinic in Brandon, started using the MACI regenerative procedure for cartilage repair, the practice said Dec. 21.

Los Angeles-based FullRange Spine & Ortho began offering regenerative treatments using a patient's own stem cells.

New Orleans Pelicans player Zion Williamson has received a biologic injection to promote bone healing in a fracture in his right foot, according to the NBA.

Two medtech companies have partnered to develop 3D-printed regenerative joint implants.

The FDA's clinical hold on Ortho RIT's Ortho-R drug has been lifted, according to a Dec. 13 news release.

Sioux Falls, S.D.-based Sanford Health launched a clinical trial examining the effectiveness of treating osteoarthritis with stem cells across five joints, Sioux Falls Business reported Dec. 8.

The California Institute for Regenerative Medicine has awarded a $5.5 million grant to a University of California Irvine professor to study the use of stem cells to treat chronic cervical spinal cord injury.

Over the past five years, the U.S. has seen a significant spike in the number of clinics advertising stem cell treatments, which claim to treat a range of orthopedic, neurological and autoimmune conditions, among others.

Theradaptive's Osteo-Adapt SP spinal fusion implant received the FDA's breakthrough medical device designation, according to a Nov. 19 news release.

Pacira Biosciences completed its acquisition of Flexion Therapeutics, according to a Nov. 19 news release.

Orthobiologics company Bioventus has signed a lease agreement to double its current operations and manufacturing space in Cordova, Tenn.

A spine biologics company's $100 million investment deal and six more key updates in regenerative medicine in the last two months: